• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to 'Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo' [Bioorg. Med. Chem. 27 (2019) 2546-2552].

作者信息

Zeng Anqi, Hua Hua, Liu Li, Zhao Junning

机构信息

Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for TCM Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu, Sichuan 610041, China.

Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for TCM Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu, Sichuan 610041, China.

出版信息

Bioorg Med Chem. 2019 Oct 1;27(19):115024. doi: 10.1016/j.bmc.2019.07.040. Epub 2019 Aug 12.

DOI:10.1016/j.bmc.2019.07.040
PMID:31416739
Abstract
摘要

相似文献

1
Corrigendum to 'Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo' [Bioorg. Med. Chem. 27 (2019) 2546-2552].《桦木酸在体外和体内诱导人结肠癌细胞凋亡并抑制其转移》的勘误 [《生物有机与药物化学》27 (2019) 2546 - 2552]
Bioorg Med Chem. 2019 Oct 1;27(19):115024. doi: 10.1016/j.bmc.2019.07.040. Epub 2019 Aug 12.
2
Corrigendum to "Eupatilin inhibits angiogenesis-mediated human hepatocellular metastasis by reducing MMP-2 and VEGF signaling" [Bioorg. Med. Chem. Lett. 28(19) (2018) 3150-3154].《“Eupatilin通过降低MMP - 2和VEGF信号传导抑制血管生成介导的人肝细胞转移”的勘误》[《生物有机与药物化学快报》28(19) (2018) 3150 - 3154]
Bioorg Med Chem Lett. 2019 Jan 15;29(2):347. doi: 10.1016/j.bmcl.2018.11.032. Epub 2018 Nov 21.
3
Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368].对《McN - 5652的结构》[《生物有机与药物化学》9 (2001) 2105]及《McN - 5652的结构》勘误[《生物有机与药物化学》10 (2002) 3368]的述评
Bioorg Med Chem. 2002 Oct;10(10):3367. doi: 10.1016/s0968-0896(02)00113-x.
4
Corrigendum to "A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells" [Bioorg. Med. Chem. 65 (2022) 116761].《“一种无不稳定腙连接子的新型生存素二聚化抑制剂诱导前列腺癌细胞自发凋亡并与多西他赛协同作用”的勘误》[《生物有机与药物化学》65 (2022) 116761]
Bioorg Med Chem. 2023 Jan 15;78:117127. doi: 10.1016/j.bmc.2022.117127. Epub 2022 Dec 12.
5
Corrigendum to "Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease" [Bioorg. Med. Chem. 23 (2015) 1102-1111].
Bioorg Med Chem. 2015 Aug 1;23(15):5077. doi: 10.1016/j.bmc.2015.06.031. Epub 2015 Jun 19.
6
Corrigendum to "Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo" [Bioorg. Med. Chem. Lett. 26 (2016) 3364-3369].
Bioorg Med Chem Lett. 2016 Sep 1;26(17):4386. doi: 10.1016/j.bmcl.2016.07.035. Epub 2016 Jul 26.
7
Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924].
Bioorg Med Chem Lett. 2017 May 1;27(9):2082. doi: 10.1016/j.bmcl.2017.02.063. Epub 2017 Mar 17.
8
Corrigendum to "Reengineered tricyclic anti-cancer agents" [Bioorg. Med. Chem. 23 (2015) 6528-6534].《“重新设计的三环抗癌剂”的勘误》[《生物有机与药物化学》23 (2015) 6528 - 6534]
Bioorg Med Chem. 2015 Dec 1;23(23):7487. doi: 10.1016/j.bmc.2015.11.002. Epub 2015 Nov 9.
9
Corrigendum to 'Design, synthesis and in vitro study of densely functionalized oxindoles as potent α-glucosidase inhibitors' [Bioorg. Med. Chem. 26(18) (2018) 4996-5005].《“作为强效α-葡萄糖苷酶抑制剂的密集功能化羟吲哚的设计、合成及体外研究”的勘误》[《生物有机与药物化学》26(18) (2018) 4996 - 5005]
Bioorg Med Chem. 2018 Dec 15;26(23-24):6153. doi: 10.1016/j.bmc.2018.11.023. Epub 2018 Nov 21.
10
Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484].《新型他克林-吡喃并吡唑衍生物的级联合成、体外胆碱酯酶抑制活性及对接研究》的勘误[《生物有机与药物化学快报》28(14)(2018)2481 - 2484]
Bioorg Med Chem Lett. 2018 Oct 1;28(18):3129. doi: 10.1016/j.bmcl.2018.08.008. Epub 2018 Aug 14.